Frank D. Lee - 30 Jan 2026 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
30 Jan 2026
Net transactions value
-$852,164
Form type
4
Filing time
03 Feb 2026, 18:23:38 UTC
Previous filing
06 Jan 2026
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Frank D. Chief Executive Officer, Director C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUTE 900, BRISBANE /s/ Kristen Williams, Attorney-in-Fact 03 Feb 2026 0001814686

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability $852,164 -41,488 -9.4% $20.54 399,013 30 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.